Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tests for comparing mark-specific hazards and cumulative incidence functions.

Peter B Gilbert1, Ian W McKeague, Yanqing Sun

  • 1Department of Biostatistics, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. pgilbert@scharp.org

Lifetime Data Analysis
|May 8, 2004
PubMed
Summary

This study introduces new nonparametric tests to assess the relationship between a hazard rate and a continuous mark variable observed at failure times. These methods help determine if treatment failure risk depends on drug resistance mutations in HIV.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

Nature communications·2026
Same author

Authors reply to letter to the editor regarding "Selective serotonin reuptake inhibitor use during pregnancy and maternal depression: a nationwide birth cohort study on risks to the mother and the newborn".

American journal of obstetrics & gynecology MFM·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026
Same author

Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine.

NPJ vaccines·2026
Same author

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Nature communications·2026
Same author

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Vaccine·2026

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Epidemiology

Background:

  • Assessing relationships between hazard rates and mark variables is crucial in applications like clinical trials.
  • Existing methods may be limited when mark variables are only observed at uncensored failure times.

Purpose of the Study:

  • To develop and validate nonparametric tests for the relationship between hazard rate functions and continuous mark variables.
  • To test the null hypothesis of independence between mark-specific hazard rates and the mark variable.

Main Methods:

  • Development of nonparametric tests based on functionals of a bivariate test process.
  • Utilizing Nelson-Aalen-type estimators and nonparametric estimators for mark-specific cumulative hazard functions.
  • Employing a simulation procedure for asymptotically correct critical values.

Related Experiment Videos

Main Results:

  • The developed testing procedures demonstrate good performance in numerical studies.
  • The tests are effective in assessing the dependence of treatment failure risk on drug resistance mutations.
  • Asymptotically distribution-free test statistics are achievable through appropriate weight function selection.

Conclusions:

  • The new nonparametric tests provide a robust method for analyzing mark-dependent hazard rates.
  • These methods can guide the development of anti-HIV therapies by assessing the impact of drug resistance.
  • The study offers valuable tools for survival data analysis in clinical and epidemiological research.